Technical Analysis for ABSI - Absci Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 4.21 | -0.94% | -0.04 |
ABSI closed down 0.94 percent on Friday, May 31, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Jun 12
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Oversold Stochastic | Weakness | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | -0.94% | |
| Stochastic Buy Signal | Bullish | -0.94% | |
| Lower Bollinger Band Walk | Weakness | -0.94% | |
| Oversold Stochastic | Weakness | -0.94% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.72% | |
| NR7 | Range Contraction | 0.72% | |
| Doji - Bullish? | Reversal | 0.72% | |
| Lower Bollinger Band Walk | Weakness | 0.72% | |
| Gapped Down | Weakness | 0.72% |
| Alert | Time |
|---|---|
| Down 3% | 1 day ago |
| Slingshot Bearish Entry | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Down 2 % | 1 day ago |
| Possible NR7 | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/12/2024
Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Artificial Intelligence Pharmacy Drug Discovery Synthetic Biology Genscript Biotech
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Artificial Intelligence Pharmacy Drug Discovery Synthetic Biology Genscript Biotech
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.72 |
| 52 Week Low | 1.1111 |
| Average Volume | 1,116,304 |
| 200-Day Moving Average | 3.31 |
| 50-Day Moving Average | 5.03 |
| 20-Day Moving Average | 4.69 |
| 10-Day Moving Average | 4.41 |
| Average True Range | 0.34 |
| RSI (14) | 37.50 |
| ADX | 14.94 |
| +DI | 18.26 |
| -DI | 24.34 |
| Chandelier Exit (Long, 3 ATRs) | 4.41 |
| Chandelier Exit (Short, 3 ATRs) | 5.04 |
| Upper Bollinger Bands | 5.36 |
| Lower Bollinger Band | 4.02 |
| Percent B (%b) | 0.14 |
| BandWidth | 28.56 |
| MACD Line | -0.22 |
| MACD Signal Line | -0.17 |
| MACD Histogram | -0.049 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.62 | ||||
| Resistance 3 (R3) | 4.63 | 4.51 | 4.55 | ||
| Resistance 2 (R2) | 4.51 | 4.41 | 4.50 | 4.52 | |
| Resistance 1 (R1) | 4.36 | 4.34 | 4.35 | 4.35 | 4.50 |
| Pivot Point | 4.24 | 4.24 | 4.23 | 4.23 | 4.24 |
| Support 1 (S1) | 4.09 | 4.14 | 4.08 | 4.08 | 3.92 |
| Support 2 (S2) | 3.97 | 4.07 | 3.96 | 3.90 | |
| Support 3 (S3) | 3.82 | 3.97 | 3.87 | ||
| Support 4 (S4) | 3.81 |
